Performance analysis of AL amyloidosis cardiac biomarker staging

Performance analysis of AL amyloidosis cardiac biomarker staging systems with special focus on renal failure and atrial arrhythmia by Tobias Dittrich, Axel Benner, Christoph Kimmich, Fabian aus dem Siepen, Kaya Veelken, Arnt V. Kristen, Tilmann Bochtler, Hugo A. Katus, Carsten Müller-Tidow, Ute Hegenbart, and Stefan O. Schönland haematol Volume 104(7): 1451 -1459 June 30, 2019 © 2019 by Ferrata Storti Foundation

Baseline characteristics of the patients and their treatment. Tobias Dittrich et al. Haematologica 2019; 104: 1451 -1459 © 2019 by Ferrata Storti Foundation

Survival of the whole cohort and the subgroups divided according to renal function and the presence or absence of atrial arrhythmias. Tobias Dittrich et al. Haematologica 2019; 104: 1451 -1459 © 2019 by Ferrata Storti Foundation

Results of univariable and multivariable analyses including different cardiac scoring systems. Tobias Dittrich et al. Haematologica 2019; 104: 1451 -1459 © 2019 by Ferrata Storti Foundation

Overall survival according to the staging systems. Tobias Dittrich et al. Haematologica 2019; 104: 1451 -1459 © 2019 by Ferrata Storti Foundation

Comparison of the MAYO 2004/3 b and MAYO 2012 staging systems. Tobias Dittrich et al. Haematologica 2019; 104: 1451 -1459 © 2019 by Ferrata Storti Foundation

Performance of the staging systems. Tobias Dittrich et al. Haematologica 2019; 104: 1451 -1459 © 2019 by Ferrata Storti Foundation